| Dr Angel L Allen, MD | |
|
580 Providence Park Dr E Fl 2, Mobile, AL 36695-4614 | |
| (251) 631-3570 | |
| (251) 631-3572 |
| Full Name | Dr Angel L Allen |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 580 Providence Park Dr E Fl 2, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780664409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 114887 (Missouri) | Secondary |
| 207N00000X | Dermatology | MD.43429 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forefront Dermatology | 3779471701 | 474 |
News Archive
Biodel Inc. announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin.
Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19).
Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label.
Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine.
› Verified 8 days ago
| Entity Name | Forefront Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366936759 PECOS PAC ID: 3779471701 Enrollment ID: O20180911002840 |
News Archive
Biodel Inc. announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin.
Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19).
Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label.
Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angel L Allen, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (920) 663-9008 | Dr Angel L Allen, MD 580 Providence Park Dr E Fl 2, Mobile, AL 36695-4614 Ph: (251) 631-3570 |
News Archive
Biodel Inc. announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin.
Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19).
Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label.
Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine.
› Verified 8 days ago
Dr. Dena Jones Howell, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4310 Old Shell Rd, Suite D, Mobile, AL 36608 Phone: 251-343-9100 Fax: 251-343-9125 | |
Virginia Jones Reeder, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E, 2nd Floor, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572 | |
Dr. John Scott Vanloock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6163 Omni Park Dr, Mobile, AL 36609 Phone: 251-635-1315 Fax: 251-635-1210 | |
Dr. Robert Neil Capper, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 5317 Oak Bend Ct, Mobile, AL 36609 Phone: 251-661-3200 | |
Aldo Trovato, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3715 Dauphin Street Building 2, 4th Floor, Mobile, AL 36608 Phone: 251-343-2100 Fax: 251-344-9944 | |
Dr. Ryan Burke Ramagosa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 70 Midtown Park E, Mobile, AL 36606 Phone: 251-289-1786 | |
Dr. Cary L. Dunn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E Fl 2, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572 |